Levitt D - Search Results

1

Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity.

Goldstein D, Sosman JA, Hank JA, Weil-Hillman G, Moore KH, Borchert A, Bechhofer R, Storer B, Kohler PC, Levitt D, et al. Goldstein D, et al. Among authors: levitt d. Cancer Res. 1989 Dec 1;49(23):6832-9. Cancer Res. 1989. PMID: 2819723

2

Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity.

Sosman JA, Aronson FR, Sznol M, Atkins MB, Dutcher JP, Weiss GR, Isaacs RE, Margolin KA, Fisher RI, Ernest ML, Mier J, Oleksowicz L, Eckhardt JR, Levitt D, Doroshow JH. Sosman JA, et al. Among authors: levitt d. Clin Cancer Res. 1997 Jan;3(1):39-46. Clin Cancer Res. 1997. PMID: 9815535 Clinical Trial.

3

Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells.

Thompson JA, Lee DJ, Lindgren CG, Benz LA, Collins C, Shuman WP, Levitt D, Fefer A. Thompson JA, et al. Among authors: levitt d. Cancer Res. 1989 Jan 1;49(1):235-40. Cancer Res. 1989. PMID: 2783243

4

A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.

Huberman M, Bering H, Fallon B, Tessitore J, Sonnenborn H, Paul S, Zeffren J, Levitt D, Groopman J. Huberman M, et al. Among authors: levitt d. Cancer. 1991 Oct 15;68(8):1708-13. doi: 10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v. Cancer. 1991. PMID: 1913512 Clinical Trial.

5

Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells.

Hoffman M, Mittelman A, Dworkin B, Rosenthal W, Beneck D, Gafney E, Arlin Z, Levitt D, Podack E. Hoffman M, et al. Among authors: levitt d. J Cancer Res Clin Oncol. 1989;115(2):175-8. doi: 10.1007/BF00397920. J Cancer Res Clin Oncol. 1989. PMID: 2785519

6

Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.

Hirsh M, Lipton A, Harvey H, Givant E, Hopper K, Jones G, Zeffren J, Levitt D. Hirsh M, et al. Among authors: levitt d. J Clin Oncol. 1990 Oct;8(10):1657-63. doi: 10.1200/JCO.1990.8.10.1657. J Clin Oncol. 1990. PMID: 2213102

7

Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation.

Thompson JA, Lee DJ, Lindgren CG, Benz LA, Collins C, Levitt D, Fefer A. Thompson JA, et al. Among authors: levitt d. J Clin Oncol. 1988 Apr;6(4):669-78. doi: 10.1200/JCO.1988.6.4.669. J Clin Oncol. 1988. PMID: 3258631

8

Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancer.

Koretz MJ, Lawson DH, York RM, Graham SD, Murray DR, Gillespie TM, Levitt D, Sell KM. Koretz MJ, et al. Among authors: levitt d. Arch Surg. 1991 Jul;126(7):898-903. doi: 10.1001/archsurg.1991.01410310108017. Arch Surg. 1991. PMID: 1854252 Clinical Trial.

9

Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.

Rinehart J, Margolin KA, Triozzi P, Hersh E, Campion M, Resta D, Levitt D. Rinehart J, et al. Among authors: levitt d. Clin Cancer Res. 1995 Oct;1(10):1139-44. Clin Cancer Res. 1995. PMID: 9815905 Clinical Trial.

10

Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2.

Mittelman A, Savona S, Gafney E, Penichet KO, Lin BY, Levitt D, Ahmed T, Arlin ZA, Baskind P, Needleman D, et al. Mittelman A, et al. Among authors: levitt d. J Biol Response Mod. 1989 Oct;8(5):468-78. J Biol Response Mod. 1989. PMID: 2795092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters